Virtus ETF Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Telecom Argentina
TEO
|
+$2.03M |
| 2 |
Methanex
MEOH
|
+$1.43M |
| 3 |
EQM
EQM Midstream Partners, LP
EQM
|
+$1.32M |
| 4 |
Carlyle Secured Lending
CGBD
|
+$1.31M |
| 5 |
The GEO Group
GEO
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oxford Square Capital
OXSQ
|
+$2.73M |
| 2 |
MPLX
MPLX
|
+$1.51M |
| 3 |
MDCO
Medicines Co
MDCO
|
+$982K |
| 4 |
Gladstone Investment Corp
GAIN
|
+$857K |
| 5 |
CELG
Celgene Corp
CELG
|
+$712K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.46% |
| 2 | Real Estate | 16.88% |
| 3 | Energy | 14.34% |
| 4 | Healthcare | 10.85% |
| 5 | Materials | 9.71% |
Similar funds
Virtus ETF Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, Virtus ETF Advisers held 532 positions worth $612M, up 23% from $496M the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Virtus ETF Advisers deployed $88.3M of net new capital in Q4 2019, opening 97 new positions and adding to 238 existing holdings. Its largest new stake was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 24% a quarter earlier, followed by Real Estate and Energy.
On the sell side, the largest reduction was Oxford Square Capital, an estimated $2.73M trimmed.
- Virtus ETF Advisers's largest Q4 2019 buy was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.
- Virtus ETF Advisers added most to Telecom Argentina in Q4 2019, an estimated $2.03M increase.
- Virtus ETF Advisers's biggest Q4 2019 reduction was Oxford Square Capital, cutting an estimated $2.73M.
- Virtus ETF Advisers fully exited Medicines Co in Q4 2019, selling an estimated $982K.
- Virtus ETF Advisers's ten largest holdings make up 9% of its $612M portfolio in Q4 2019.
- Virtus ETF Advisers opened 97 new positions and closed 80 in Q4 2019.
- Virtus ETF Advisers's portfolio value rose 23% quarter-over-quarter to $612M.
Based on Virtus ETF Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.